ASPIRIN LOWERS DIABETES RISK DURING COVID-19, BUT NOT WITHOUT SIDE EFFECTS

By Vijay Kumar Malesu

New research suggests that taking a daily aspirin may halve your risk of developing diabetes, especially during the COVID-19 pandemic, by targeting inflammation, but not without trade-offs.

Study: Aspirin reduces the risk of type 2 diabetes associated with COVID-19. Image Credit: Studio Romantic / Shutterstock

In a recent study published in the journal npj Metabolic Health and Disease, a group of researchers assessed whether daily low-dose aspirin reduces the risk of new-onset type 2 diabetes (T2D) associated with Coronavirus Disease 2019 (COVID-19).

Background

T2D affects over 500 million people globally, and its incidence sharply increased during the COVID-19 pandemic. Several factors, including stress, poor dietary habits, reduced physical activity, and limited access to healthcare, may have contributed to this rise in cases.

Read the full story here.

2025-06-20T01:36:58Z